Event on

Cardiovascular risk assessment and prevention: where do we stand?

Background

Cardiac biomarkers and lipids might play a major role in the prevention of cardiovascular diseases.

Join this session to learn from experts in cardiovascular disease prevention about the recent evidence on risk stratification, to get insights from their daily clinical practice and to learn how to use cardiac biomarkers and lipid profile in a more efficient way.

プレゼンテーション

  • Carolyn S. P. Lam

    Carolyn S. P. Lam
    (Singapore, SG)
    Chairperson

    Welcome and Introduction

    English

  • Naveed Sattar

    Naveed Sattar
    (Glasgow, UK)
    Speaker

    The role of troponins in primary prevention of CV events: Case report

    English

  • Torbjørn Omland

    Torbjørn Omland
    (Oslo, NO)
    Speaker

    Practical recommendations for the management of patients with CV disease by using hsTnI

    English

  • Gottfried Rudofsky

    Gottfried Rudofsky
    (Olten, CH)
    Speaker

    The confirmed role of LDL-cholesterol for the prevention and management of cardiovascular disease in patients with diabetes

    English


提示された見解および意見は、著者のみのものです。 このWebキャストに含まれるコンテンツは、情報提供/教育目的のみを目的としています。

© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000